Additional therapies used with exercise therapy for hip or knee osteoarthritis
Osteoarthritis is the commonest type of arthritis and there are Cochrane reviews for many interventions that might be used to treat it. These were added to in October 2022 with a new review of the effects of using adjunctive therapies along with land-based exercise therapy for osteoarthritis of the hip or knee. In this podcast, podcast editor Mike Clarke speaks with lead author Helen French from the Royal College of Surgeons in Ireland, about the importance of the review and its findings. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - January 20, 2023 Category: General Medicine Authors: Cochrane Source Type: podcasts
Helmet Ventilation for COVID-19, Rheumatoid Arthritis and Immune-Mediated Inflammatory Disease Treatment, Diagnosis and Management of Stable Angina, and more
Editor's Summary by Mary McDermott, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the May 4, 2021 issue. (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - May 4, 2021 Category: General Medicine Authors: JAMA Network Source Type: podcasts
Initial safety trial results find increased risk of serious heart-related problems and cancer with arthritis and ulcerative colitis medicine Xeljanz, Xeljanz XR (tofacitinib)
Listen to FDA Drug Safety Podcast on Drug Safety Communication titled "Initial safety trial results find increased risk of serious heart-related problems and cancer with tofacitinib (Xeljanz, Xeljanz XR) (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - February 8, 2021 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
FDA approves Boxed Warning about increased risk of blood clots and death with higher dose of arthritis and ulcerative colitis medicine tofacitinib (Xeljanz, Xeljanz XR)
Listen to an audio podcast of the July 26, 2019 FDA Drug Safety Communication on FDA approval of Boxed Warning about increased risk of blood clots and death with higher dose of arthritis and ulcerative colitis medicine tofacitinib (Xeljanz, Xeljanz XR). (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - December 21, 2019 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
Safety trial finds risk of blood clots in the lungs and death with higher dose of tofacitinib (Xeljanz, Xeljanz XR) in rheumatoid arthritis patients; FDA to investigate
(Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - December 21, 2019 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
Talk Evidence - digital clubbing, osteoarthritis & sustainable EBM
We ’re back for the December Talk Evidence, and this month we’re being very digital
Firstly,(1.20) Helen tells us about arthritic fingers - should we be using prednisolone for treatment when people have painful osteoarthritis of the hand
Then (13.30) Carl gets us all to check our fingers for club bing, and we find out how useful it is as a test... (Source: The BMJ Podcast)
Source: The BMJ Podcast - December 16, 2019 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
Talk Evidence - digital clubbing, osteoarthritis & sustainable EBM
We ’re back for the December Talk Evidence, and this month we’re being very digital
Firstly,(1.20) Helen tells us about arthritic fingers - should we be using prednisolone for treatment when people have painful osteoarthritis of the hand
Then (13.30) Carl gets us all to check our fingers for club bing, and we find out how useful it is as a test for lung cancer
(23.10) Minna Johansson GP and Cochrane Sweden researcher explains why EBM needs to take into account sustainability, and why that isn’t just carbon footprint.
(33.50) We talk AF and the Apple Watch - and why drop out is going to b e a massive problem for t...
Source: The BMJ Podcast - December 16, 2019 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
Talk Evidence - digital clubbing, osteoarthritis & sustainable EBM
We’re back for the December Talk Evidence, and this month we’re being very digital
Firstly,(1.20) Helen tells us about arthritic fingers - should we be using prednisolone for treatment when people have painful osteoarthritis of the hand
Then (13.30) Carl gets us all to check our fingers for clubbing, and we find out how useful it is as a test for lung cancer
(23.10) Minna Johansson GP and Cochrane Sweden researcher explains why EBM needs to take into account sustainability, and why that isn’t just carbon footprint.
(33.50) We talk AF and the Apple Watch - and why drop out is going to be a massive problem for the ...
Source: The BMJ Podcast - December 16, 2019 Category: General Medicine Authors: BMJ Group Source Type: podcasts
FDA approves Boxed Warning about increased risk of blood clots and death with higher dose of arthritis and ulcerative colitis medicine tofacitinib (Xeljanz, Xeljanz XR)
Listen to an audio podcast of the July 26, 2019 FDA Drug Safety Communication on FDA approval of Boxed Warning about increased risk of blood clots and death with higher dose of arthritis and ulcerative colitis medicine tofacitinib (Xeljanz, Xeljanz XR). (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - August 5, 2019 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
Filgotinib for Treatment-Resistant Rheumatoid Arthritis, Intensive vs Standard Glucose Management in Acute Stroke, Neuroimaging Finding in US Cuban Government Personnel, and more
Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the July 23, 2019 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - July 23, 2019 Category: General Medicine Authors: JAMA Network Source Type: podcasts
Safety trial finds risk of blood clots in the lungs and death with higher dose of tofacitinib (Xeljanz, Xeljanz XR) in rheumatoid arthritis patients; FDA to investigate
(Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - July 12, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: podcasts
